Pharmaceutical Executive
Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.
All News - PharmExec
The New Drug Application for TAR-200 is supported by results from the Phase IIb SunRISe-1 study, which demonstrated an 83.5% complete response in patients with Bacillus Calmette …
2024 Pharm Exec Top 50 Companies
Jun 14, 2024 · As we noted in last year’s report, Novo Nordisk and Eli Lilly, competing in the lucrative GLP-1 receptor agonist space that, of late, has captivated the US and beyond in …
Pharmaceutical Executive - PharmExec
Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.
2022 Pharm Exec Top 50 Companies
Jun 9, 2022 · If 2020 was the “Year of COVID,” as we referred to it in our Pharm Exec 50 feature last year—reflecting on the pandemic’s scope and disruption on all facets of life—then 2021 …
2023 Pharm Exec Top 50 Companies
Jun 10, 2023 · Movers and shakers. As mentioned, Pfizer and AbbVie captured the top two spots again in the Pharma 50—the latter, notably, expected to maintain its solid momentum, even …
Pharmaceutical Executive APEX Awards - PharmExec
Your advertising is all about health care. Our judges are all from health care — doctors, nurses, thought leaders, patients and more. If you want to know what impact your work has on these …
Choosing the Right Track: Pharma & Healthcare MBAs - PharmExec
Oct 26, 2018 · A growing range of MBAs with concentrations in pharmaceuticals and healthcare management are on offer. Pharm Exec look at how three of the top programs in the US …
Understanding IDNs and What They Mean to the Pharmaceutical …
Aug 2, 2024 · Integrated Delivery Networks have changed the healthcare landscape over the past decade. Greg Skalicky, president and chief revenue officer at EVERSANA, spoke with …
Out-licensing Deals Between Chinese Pharma and Global
Jan 19, 2024 · In 2023, we witnessed considerable changes in the Chinese pharmaceutical market, especially a booming market of innovative drugs and out-licensing arrangements …